Drug Injury Watch

Side Effects News & Reports

From 2005 to the Present

All Articles by Tom Lamb

Tag: law

Legal Claims May Be Possible In California For Gianvi, Zarah, Loryna, Syeda, And Vestura (Generic YAZ / Yasmin) Blood Clot Side Effects Due To Pikerie v. Teva Case Ruling

August 22, 2013

California Appellate Court In June 2013 Said Alendronate (Generic Fosamax) Lawsuits Against Companies Like Barr, Teva, And Watson Not Pre-empted (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE: "Supreme Court Rejects Teva Appeal in Drug…
Continue reading…
Merck Continues To Dispute Scheinberg Fosamax Plaintiff Verdict At June 2013 Hearing Before Judge Keenan Concerning The ONJ Warnings Aspect Of Case

June 26, 2013

Defense Lawyers Contend Scheinberg Trial Jury Acted Irrationally Because No Rational Juror Could Find The Fosamax Label Was Inadequate As Regards The Osteonecrosis of Jaw Side Effect Risk (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________…
Continue reading…
First Fosamax – Femur Fracture Trial In New Jersey State Court Scheduled To Start March 4, 2013

February 18, 2013

Judge Higbee Will Preside Over Joint Trial Of Unanski v. Merck Case And Su v. Merck Case; These Two Lawsuits Will Be Tried Together But With Separate Jury Verdicts (Posted by Tom Lamb at…
Continue reading…
Despite FDA Regulations, Generic Drug Labels Often Failed To Match Brand Name Drug Safety Warnings

December 18, 2012

Two-Thirds Of The Generics Did Not Have Identical Labeling, And Up To 9% Showed Differences Of More Than 10 Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A disturbing new study about drug labeling for generic medications…
Continue reading…
November 2012 Litigation And Settlements Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits

November 26, 2012

Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter…
Continue reading…
Fresenius GranuFlo Product Has Been Associated With Heart Problems And Cardiopulmonary Arrest During Dialysis Treatment

October 30, 2012

Fresenius Failed To Warn About Risks Of Sudden Heart Attack, Stroke, And Death Caused By GranuFlo Increasing The Level Of Bicarbonate In Blood (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Federal court GranuFlo…
Continue reading…
NuvaRing: Plaintiffs’ Expert Reports Made Available By New Jersey Judge Based On Public’s Right Of Access To Judicial Proceedings

October 24, 2012

Defendants Had Sought To Keep Sealed Some Documents That Show NuvaRing Estrogen Levels Were Apparently Concealed Or Misrepresented By Organon (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: A similar Order was issued on…
Continue reading…
Third Boles vs. Merck Fosamax Trial In September 2012 Involves Only The Damages Amount Aspect

September 6, 2012

Brief History Of This ONJ / Jaw Lawsuit: First, Mistrial; Second, Jury Verdict For Plaintiff But Award Reduced By Judge (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: We have been informed that there will not be a…
Continue reading…
Increasing Number Of Pradaxa Lawsuits Against Boehringer Are Consolidated In Federal Court MDL

August 20, 2012

This Pradaxa MDL Case Will Include Gastrointestinal Bleeding And Other Hemorrhages As Well As Heart Attacks Or Myocardial Infarctions (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa is a blood-thinning drug used to reduce the risk of…
Continue reading…
Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date

July 31, 2012

Almost 2,000 Lawsuits With Blood Clots Such As DVT And PE Settled, With At Least Another 4,000 Such Cases In Settlement Mediation Negotiations (Posted by Tom Lamb at DrugInjuryWatch.com) From Bayer's Stockholders' Newsletter Second…
Continue reading…